Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

(Reuters) -Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood ...

A biologics license application for pivekimab sunirine (PVEK) has been submitted to the U.S. Food and Drug Administration ...

Activists have highlighted that far more land than required has been allocated for these blood banks, and that too at ...

An epidemic of Type 2 diabetes continues to plague the United States, leading to calls for reassessing how the disease is ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

The new tools and resources for assessing your health and risks.

Sept 19 (Reuters) - Regeneron (REGN.O), opens new tab said on Friday its experimental therapy showed either a complete or partial disappearance of a precancerous disorder, which manifests into blood ...

A recent study by ConsumerAffairs ranked the top 25 cities have the worst drivers in the United States. Did yours make the ...

A practical look at the challenges of diagnosing and managing feline hyperthyroidism, from misleading symptoms to complex ...

Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.

BMC accused of abandoning affordable healthcare as PPP shift pushes essential treatment beyond the reach of those who need it ...